HedgeMountain

Blackbarn Capital Partners LP

New York, NY · CRD 319137
Hedge fund manager

Blackbarn Capital Partners LP is an SEC-registered investment adviser based in New York, NY that reports managing 1 hedge fund on Form ADV. It reports $1.2 billion in regulatory assets under management. Its private funds, of all types, hold $1.2 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +33.3% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +91.5% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$1.2 billionForm ADV Item 5.F
Gross assets of private funds
$1.2 billionAll private fund types, Form ADV
Hedge funds managed
11 private funds in total
Employees
11Form ADV Item 5.A
Registration
SEC-registered adviserCRD 319137
Latest Form ADV
03/20/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Est. 2026 YTD+33.3%Through Q2 2026 · S&P 500 +9.5%
Est. 2-year return+91.5%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$402.2 million17 positions, 2026-06-30
$100$146$192Q3 2024Q1 2025Q3 2025Q1 202613F est. $192S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+26.8%+14.8%
Q1 2026+5.2%-4.6%
Q4 2025+16.6%+2.4%
Q3 2025+18.7%+7.8%
Q2 2025+2.5%+10.4%
Q1 2025-5.1%-4.5%
Q4 2024-5.6%+2.1%
Q3 2024+13.2%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Largest disclosed holdings

  • Roivant Sciences LTD SHS$70.8 million
  • Privia Health Group Inc$40.8 million
  • Diversified Healthcare TR$37.9 million
  • Nextera Energy Inc SHS$29.4 million
  • Niq Global Intelligence PLC$27.2 million
  • Unitedhealth Group Inc$27.0 million
  • NXP Semi$25.3 million
  • Viking Therapeutics Inc$23.4 million
  • Mcgraw Hill Inc$23.2 million
  • Amneal Pharmaceuticals Inc$22.5 million

As of 2026-06-30, from 13F filing by BlackBarn Capital Partners LP.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures